Abbvie Inc.

Margaret Hugunin

Chung-Ming Hsieh

Jennifer Maria Perez

Yuliya Kutskova

John Memmott

Anca Clabbers

Suju Zhong

Edit Tarcsa

Mary Leddy

Anwar Murtaza

Bradford L McRae

Shaughn H Bryant

Craig Wallace

Tariq Ghayur

Chengbin Wu

Lorenzo Benatuil

Rajesh Vasant Kamath

Hamish John Allen

Lisa Maria Olson

Peter C Isakson

Carolyn A Cuff

Alyssa Brito

Lucia Eaton

Proteins that bind IL-17 and/or IL-17F are described along with their use in composition and methods for treating, preventing, and diagnosing IL-17 related diseases and for detecting IL-17 in cells, tissues, samples, and compositions.

IL-17 binding proteins

Engineered multivalent and multispecific binding proteins, methods of making, and specifically to their uses in the prevention, diagnosis, and/or treatment of disease are provided.

Bispecific antibodies directed against TNF-&#x3b1; and IL-17

Proteins that bind IL-17 and/or IL-17F are described along with their use in compositions and methods for treating, preventing, and diagnosing IL-17 related diseases and for detecting IL-17 in cells, tissues, samples, and compositions.

The present invention relates to engineered multivalent and multispecific binding proteins, methods of making, and specifically to their uses in the prevention, diagnosis, and/or treatment of disease.

Dual variable domain immunoglobulins and uses thereof

Proteins that bind IL-17 and/or IL-17F are described along with there use in composition and methods for treating, preventing, and diagnosing IL-17 related diseases and for detecting IL-17 in cells, tissues, samples, and compositions.

Growing community of inventors

North Grafton, MA, United States of America

Margaret Hugunin